Status | Study |
Withdrawn |
Study Name: Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli Condition: Patent Foramen Ovale Cardiac Implantable Electronic Device Date: 2015-02-27 Interventions: Drug: Apixaban Patients who me |
Completed |
Study Name: Identification the Cause of Silent Cerebral infarctiON in Healthy Subjects (ICONS) Condition: Cerebral Infarction Date: 2011-09-06 |
Available |
Study Name: PFO ACCESS Registry Condition: Patent Foramen Ovale Stroke Date: 2007-12-21 Interventions: Device: Device closure with the AMPLATZER PFO Occluder Device closure with the AMPLATZER PFO Occluder |
Withdrawn |
Study Name: Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism Condition: Patent Foramen Ovale Date: 2005-09-12 Interventions: Device: PFX Closure System |
Available |
Study Name: Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO) Condition: Patent Foramen Ovale Stroke Ischemic Attack, Transient Date: 2005-09-12 Interventions: Device: STARFlex septal closure system |
Recruiting |
Study Name: PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism Condition: Embolism, Paradoxical Heart Septal Defects, Atrial Date: 2005-09-09 Interventions: Device: Percutaneous closure of patent foramen ovale |